Home/Filings/4/0000874716-24-000034
4//SEC Filing

Erickson Michael G 4

Accession 0000874716-24-000034

CIK 0000874716other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 5:54 PM ET

Size

28.9 KB

Accession

0000874716-24-000034

Insider Transaction Report

Form 4
Period: 2024-02-14
Erickson Michael G
Executive Vice President
Transactions
  • Tax Payment

    Common Stock

    2024-02-14$560.56/sh144$80,72110,657.362 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-1495282 total
    Common Stock (95 underlying)
  • Exercise/Conversion

    Common Stock

    2024-02-14+9710,544.362 total
  • Exercise/Conversion

    Common Stock

    2024-02-14+9310,706.362 total
  • Exercise/Conversion

    Common Stock

    2024-02-14+6910,613.362 total
  • Award

    Restricted Stock Unit

    2024-02-14+1,2041,204 total
    Common Stock (1,204 underlying)
  • Exercise/Conversion

    Common Stock

    2024-02-14+10810,447.362 total
  • Exercise/Conversion

    Common Stock

    2024-02-14+9510,801.362 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-1493185 total
    Common Stock (93 underlying)
  • Award

    Incentive Stock Option (right-to-buy)

    2024-02-14+178178 total
    Exercise: $560.56Exp: 2034-02-13Common Stock (178 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-14970 total
    Common Stock (97 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-146969 total
    Common Stock (69 underlying)
  • Award

    Non-Qualified Stock Option (right-to-buy)

    2024-02-14+5,4075,407 total
    Exercise: $560.56Exp: 2034-02-13Common Stock (5,407 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-141080 total
    Common Stock (108 underlying)
Footnotes (8)
  • [F1]Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025.
  • [F2]Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028.
  • [F3]Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025.
  • [F4]Each RSU represents a contingent right to receive one share of Issuer common stock and vesedt in five annual installments beginning on February 14, 2020.
  • [F5]Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments beginning on February 14, 2021.
  • [F6]Each RSU represents a contingent right to receive one share of Issuer. common stock and vest in four annual installments beginning on February 14, 2022.
  • [F7]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2023.
  • [F8]Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2024.

Issuer

IDEXX LABORATORIES INC /DE

CIK 0000874716

Entity typeother

Related Parties

1
  • filerCIK 0002005385

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:54 PM ET
Size
28.9 KB